Acute exacerbation of interstitial lung disease after transthoracic biopsy

Medeiros,Augusto Kreling

DOI: https://doi.org/10.36416/1806-3756/e20230426

2024-09-28

Jornal Brasileiro de Pneumologia

Abstract:We report the case of an 80-year-old male with a recent diagnosis of advanced-stage lung adenocarcinoma, confirmed through transthoracic biopsy (TTB) in the right upper lobe, metastatic to bones and subcutaneous tissue. The patient had a 10-year history of rheumatoid arthritis, treated with adalimumab. He also had fibrotic rheumatoid arthritis-associated interstitial lung disease (RA-ILD) with combined pulmonary fibrosis and emphysema (CPFE) and fibrosis with a typical usual interstitial pneumonia (UIP) pattern; coronary artery disease requiring stent placement; symptomatic bradycardia requiring a pacemaker; and chronic kidney disease of undefined cause. He had a 20-pack-year smoking history and had ceased smoking 10 years prior. The patient was admitted to undergo a repeat TTB to collect material for a mutation panel and programmed death ligand 1 testing, given that the initial biopsy yielded insufficient material. Before the procedure, the patient had not undergone any oncological treatments. One week before this hospitalization, the patient experienced a small-volume hemoptysis episode, leading to a short (48-h) admission for bronchoscopy investigation. Signs of active bleeding from the right upper lobe were observed. Epinephrine was administered locally, and bronchial artery arteriography with selective embolization was performed, resulting in no further episodes of hemoptysis. No BAL or TTB was performed at that time. On physical examination before the new lung biopsy, the RR was 16 breaths/min, the HR was 70 bpm, the SpO 2 was 94% on room air, and there were basal crackles. Laboratory tests at admission showed abnormal renal function abnormalities (consistent with the preexisting condition of the patient) and findings consistent with anemia of chronic disease. An initial HRCT revealed a neoplastic mass in the right lung, together with CPFE (Figure 1, A-E). Ground-glass opacities surrounding the mass and other nodular lesions corresponded to perilesional hemorrhage identified within the context of hemoptysis. The patient underwent TTB, during which there were no complications and mechanical ventilation was not required. He was discharged the following day. The TTB confirmed a pattern of interstitial fibrosis with the spatial heterogeneity typically found in UIP, along with other areas of tumor infiltration into the lung parenchyma. Ten days after the procedure, the patient returned to the emergency department with complaints of increased exertional dyspnea, a drop in SpO 2 to 86% on room air, without fever, cough, sputum production, or upper airway symptoms. The RR was 28 breaths/min, the HR was 98 bpm, and pulmonary auscultation revealed worsening crackles up to the middle third of the lung. A repeat chest HRCT showed new diffuse bilateral ground-glass opacities (Figure 1, F-J). Initial diagnostic hypotheses included an infectious process or an acute exacerbation of ILD (AE-ILD). At this point, empirical antibiotic therapy with piperacillin-tazobactam and azithromycin was initiated, and infectious causes were investigated. The results of blood cultures, urine culture, PCR for cytomegalovirus, an extended molecular panel for viruses and bacteria, and urine antigen tests for Legionella sp. and Streptococcus sp. were all unremarkable, as were those of tests for procalcitonin, galactomannan, B-type natriuretic peptide, and troponin. There was no new organ dysfunction. Given the exclusion of infectious processes and the daily worsening of hypoxemia, the most probable diagnosis was determined to be an AE-ILD. Therapy with methylprednisolone (1 mg/kg/day), as well as oral morphine for dyspnea, was initiated on post-admission day 4. Progressively, the patient experienced worsening gas exchange and the need for increased oxygen flow. On post-admission day 7, the use of a high-flow nasal cannula was required, at a flow rate of 60 L/min and an FiO 2 of 80%, achieving an SpO 2 of 85%. The patient developed mental confusion and respiratory discomfort, prompting the initiation of palliative sedation in accordance with the patient's advance care directive. On post-admission day 15, the patient died. The ILD category encompasses a diverse group of pulmonary disorders, characterized by varying degrees of inflammation and fibrosis, whose prognosis varies widely depending on the specific pathology. 1 1 Kalchiem-Dekel O, Galvin JR, Burke AP, Atamas SP, Todd NW. Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History. J Clin Med. 2018;7(12):476. https://doi.org/10.3390/jcm7120476 https://doi.org/10.3390/jcm7120476... Although the diagnostic approach to ILDs and their potential comorbidities, such as lung cancer, often ne -Abstract Truncated-

respiratory system